These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28632424)

  • 21. Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrel.
    Gremmel T; Eslam RB; Koppensteiner R; Lang IM; Panzer S
    Cardiovasc Ther; 2013 Oct; 31(5):e40-5. PubMed ID: 23311679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
    Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K
    Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G-protein-coupled receptors as signaling targets for antiplatelet therapy.
    Smyth SS; Woulfe DS; Weitz JI; Gachet C; Conley PB; Goodman SG; Roe MT; Kuliopulos A; Moliterno DJ; French PA; Steinhubl SR; Becker RC;
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):449-57. PubMed ID: 19023091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).
    Xie Z; Feng S; Wang Y; Cao C; Huang J; Chen Y; Kong Y; Li Z
    Eur J Med Chem; 2015 Sep; 102():363-74. PubMed ID: 26298494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM; Buckland RJ; Holgate CE; Storey RF
    Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.
    Natarajan A; Zaman AG; Marshall SM
    Diab Vasc Dis Res; 2008 Jun; 5(2):138-44. PubMed ID: 18537103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy.
    Lippi G; Montagnana M; Danese E; Favaloro EJ; Franchini M
    Biomark Med; 2011 Feb; 5(1):63-70. PubMed ID: 21319966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent therapeutic approaches to platelet activation in coronary artery disease.
    Tousoulis D; Paroutoglou IP; Papageorgiou N; Charakida M; Stefanadis C
    Pharmacol Ther; 2010 Aug; 127(2):108-20. PubMed ID: 20546778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.
    Tautz L; Senis YA; Oury C; Rahmouni S
    Bioorg Med Chem; 2015 Jun; 23(12):2786-97. PubMed ID: 25921264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advance in antiplatelet therapy: the mechanisms, evidence and approach to the problems.
    Horiuchi H
    Ann Med; 2006; 38(3):162-72. PubMed ID: 16720431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antiplatelet effects of a new nitroderivative of acetylsalicylic acid--an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production.
    Lechi C; Andrioli G; Gaino S; Tommasoli R; Zuliani V; Ortolani R; Degan M; Benoni G; Bellavite P; Lechi A; Minuz P
    Thromb Haemost; 1996 Nov; 76(5):791-8. PubMed ID: 8950792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
    Rozalski M; Nocun M; Watala C
    Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.
    Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet activation and inhibition in sickle cell disease (pains) study.
    Frelinger AL; Jakubowski JA; Brooks JK; Carmichael SL; Berny-Lang MA; Barnard MR; Heeney MM; Michelson AD
    Platelets; 2014; 25(1):27-35. PubMed ID: 23469943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet and anticoagulant therapy for atherothrombotic disease: the role of current and emerging agents.
    Angiolillo DJ; Ferreiro JL
    Am J Cardiovasc Drugs; 2013 Aug; 13(4):233-50. PubMed ID: 23613159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
    Madsen NJ; Holmes CE; Serrano FA; Sobel BE; Schneider DJ
    Am J Cardiol; 2007 Aug; 100(4):722-7. PubMed ID: 17697836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF; Chang CH; Ho PL; Chung CH
    Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of ketone-based P2Y(12) receptor antagonists as antithrombotic agents: pharmacodynamics and receptor kinetics considerations.
    Giordanetto F; Bach P; Zetterberg F; Antonsson T; Bylund R; Johansson J; Sellén M; Brown D; Hideståhl L; Berntsson P; Hovdal D; Zachrisson H; Björkman JA; van Giezen JJ
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2963-8. PubMed ID: 24835983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.